Integra LifeSciences Holdings Corporation Forecast, price target & analysts
Integra LifeSciences Holdings Corporation Target price 2024 - Analyst rating & recommendation
Integra LifeSciences Holdings Corporation Classifications & Recommendation:
Integra LifeSciences Holdings Corporation Target price
| Target price | $34.20 |
| Course | $29.14 |
| Price potential |
17.36%
register free of charge
|
| Number of estimates | 10 |
|
10 Analysts have issued a price target Integra LifeSciences Holdings Corporation 2025 .
The average Integra LifeSciences Holdings Corporation target price is $34.20.
This is
17.36%
register free of charge
$51.00
75.02%
register free of charge
$24.00
17.64%
register free of charge
|
|
| A rating was issued by 14 analysts: 3 Analysts recommend Integra LifeSciences Holdings Corporation to buy, 8 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Integra LifeSciences Holdings Corporation share has an average upside potential 2025 of
17.36%
register free of charge
|
Sales and margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Billion $ | 1.54 | 1.67 |
| 1.03% | 8.34% | |
| EBITDA margin | 19.30% | 22.15% |
| 13.78% | 14.74% | |
| Net margin | 4.29% | 5.30% |
| 60.70% | 23.51% |
12 Analysts have issued a sales forecast Integra LifeSciences Holdings Corporation 2024 . The average Integra LifeSciences Holdings Corporation sales estimate is
This results in the following potential growth figures:
8 Analysts have issued an Integra LifeSciences Holdings Corporation EBITDA forecast 2024. The average Integra LifeSciences Holdings Corporation EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
3 Integra LifeSciences Holdings Corporation Analysts have issued a net profit forecast 2024. The average Integra LifeSciences Holdings Corporation net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | 0.84 | 1.12 |
| 61.11% | 33.33% | |
| P/E ratio | 25.94 | |
| EV/Sales | 2.20 |
3 Analysts have issued a Integra LifeSciences Holdings Corporation forecast for earnings per share. The average Integra LifeSciences Holdings Corporation <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the Integra LifeSciences Holdings Corporation share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Integra LifeSciences Holdings Corporation...
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
